key: cord-0910688-7xlhy3yr authors: Nillawar, A. N.; Chavan, M. N.; Gayatri, S.; Patil, S.; Deshpande, J.; Yadav, A.; Nakate, P. title: Anatomy of Covid outbreak of vaccinated: An observational case-control study of Covid breakthrough infections in medical college students at Rural Medical College, India date: 2022-01-28 journal: nan DOI: 10.1101/2022.01.27.22269902 sha: 92ab47f40728e23e4bc508ec693d80a87934390d doc_id: 910688 cord_uid: 7xlhy3yr Introduction Breakthrough infections in reference to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported worldwide in both partially or completely vaccinated individuals irrespective of the type of vaccine. India, also emerged as the vaccine powerhouse producer, initiating the worlds one of the largest vaccination drives since January 16, 2021, with two vaccines named, BBV-152(COVAXINTM) and AZD1222 (COVISHIELDTM). Breakthrough cases are reported from all over the globe for all kinds of vaccines. This is the investigation report into the outbreak of breakthrough covid infections at one of the medical colleges in Rural India unraveled in early October 2021. This report underscores the role of covid appropriate behavior along with vaccination and the role of IgG in evaluating immunity generated through vaccination. Objective: The study objective was to 1. Clinically characterize the recent breakthrough infection of Covid-19 (SARS- CoV-2) infection among (students) vaccinated in BKL Walawalkar Rural Medical College. 2. To evaluate Covid appropriate behavior, (CAB) in cases and controls. 3. To evaluate Covid anti spike IgG in the cases in comparison with the control Methods A total of 74 students studying at BKL Walawalkar Rural Medical College and vaccinated for Covid were included in the study. RT-PCR diagnosis was done from 5 to 10 October 2021. The breakthrough infection in the cases was characterized using self-assessment questionnaires in comparison to the controls. The cases were assessed clinically and also using biochemical parameters. Both cases and controls were also assessed for their adherence to covid appropriate behavior using a separate semi-quantitative questionnaire and scoring system. Results In our study, out of the total subjects, 50% of Covaxin recipients had experienced vaccine breakthrough infection and 20% of Covishield recipients experienced breakthrough infection. Also, 6 out of the 35 cases were asymptomatic, and the rest were either having mild symptoms. None of them required any hospitalization or O2 therapy. The CAB score was lower in the cases when compared to controls. All the vaccine recipients are seroconvert. Anti-spike IgG antibodies titers are dynamic over time and across the clinically distinct groups. Irrespective of varying IgG titer, the vaccine protects against severity and possibly mortality. Conclusion The need for better awareness of covid appropriate methods as an alternative to and additive to vaccination is necessary to control the transmission of Covid infection and decrease the disease severity. Vaccines are effective against preventing severe disease and possibly mortality. The use of serum anti-spike covid IgG is restricted to know the status of SARS-CoV-2 seroconversion. Keywords Breakthrough infection; SARS-CoV-2; Covid-19 vaccination, covid appropriate behavior, Anti-spike-IgG seroconversion Breakthrough infections in reference to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported worldwide in both partially or completely vaccinated individuals irrespective of the type of vaccine. India, also emerged as the vaccine powerhouse producer, initiating the world's one of the largest vaccination drives since January 16, 2021, with two vaccines named, BBV-152(COVAXIN TM ) and AZD1222 (COVISHIELD TM ). Breakthrough cases are reported from all over the globe for all kinds of vaccines. This is the investigation report into the outbreak of breakthrough covid infections at one of the medical colleges in Rural India unraveled in early October 2021. This report underscores the role of covid appropriate behavior along with vaccination and the role of IgG in evaluating immunity generated through vaccination. Objective: The study objective was to 1. Clinically characterize the recent breakthrough infection of Covid-19 (SARS-CoV-2) infection among (students) vaccinated in BKL Walawalkar Rural Medical College. 2. To evaluate 'Covid appropriate behavior' (CAB) in cases and controls. 3. To evaluate Covid anti spike IgG in the cases in comparison with the control A total of 74 students studying at BKL Walawalkar Rural Medical College and vaccinated for Covid were included in the study. RT-PCR diagnosis was done from 5 to 10 October 2021. The breakthrough infection in the cases was characterized using self-assessment questionnaires in comparison to the controls. The cases were assessed clinically and also using biochemical parameters. Both cases and controls were also assessed for their adherence to covid appropriate behavior using a separate semi-quantitative questionnaire and scoring system. In our study, out of the total subjects, 50% of Covaxin recipients had experienced vaccine breakthrough infection and 20% of Covishield recipients experienced breakthrough infection. Also, 6 out of the 35 cases were asymptomatic, and the rest were either having mild symptoms. None of them required any hospitalization or O2 therapy. The CAB score was lower in the cases when compared to controls. All the vaccine recipients are seroconvert. Anti-spike IgG antibodies titers are dynamic over time and across the clinically distinct groups. Irrespective of varying IgG titer, the vaccine protects against severity and possibly mortality. s t i g a t i o n s a n d d a t a c o l l e c t i o n a n d c o n t r i b u t e d i n m a n u s c r i p t w r i t i n g , J D a n d S P p r o v i d e d c r u c i a l c l i n i c a l d a t a a b o u t h o s p i t a l i z e d p a t i e n t s , A Y r e v i e w e d m a n u s c r i p t a n d c o n t r i b u t e d i n d a t a c o l l e c t i o n , P N g a v e R T -P C R i n p u t s , A N c o n c e p t u a l i z e d t h e p a p e r , p r e p a r e d s t u d y d e s i g n a n d p r e p a r e d C R F a n d d i d m a n u s c r i p t w r i t i n g a n d o v e r s e e l a b o r a t o r y i n v e s t i g a t i o n s . . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 28, 2022. 6 According to the ICMR between 0.02 and 0.04% of infections have occurred after partial or complete vaccination with either BBV152 or AZD1222 (ChAdOx1-S). 4 The current study attempts to characterize covid breakthrough infections to concerning clinical symptomatology, vaccination status, and inclination and awareness towards Covid appropriate behavior. This is pursued by using a self-assessment semi-quantitative questionnaire in simple understandable language. This study would provide crucial evidence in understanding not only the vaccine effectiveness but also the need for strict adherence to appropriate behavior in preventing transmission and decrease in the severity of the disease. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 28, 2022. The rationale for selecting the study group: The study group is in many ways a closed group. Being in the same age group and staying in the hostel campus before and after vaccination and during this investigation. Hence, there is less chance of bias on the exposure to external sources of infection. Hence, there is a considerable chance that the transmission was from the index case and later on the spread to the rest of the class and was also restricted only to the close contacts of the infected. In a way, this can be described as a point source outbreak. Also, all of them were vaccinated at around a similar time. (March-April 2021) This helps in understanding the clinical effectiveness of the vaccine. To assess the kinetics of antibody response, we evaluated titers of Covid anti-spike IgG. All nasopharyngeal swab samples were tested in an automated PCR machine, Roche LC-96. This targets two genes that are ORF-1 and E gene. Anti-spike . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 28, 2022. The total maximum score possible in the clinical questionnaire is 230 and for CAB is 50. (Annexure). The study protocol was approved by the Institutional Ethics Committee. Written consent was obtained from the subjects before the initiation of the study. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 28, 2022. ; https://doi.org/10.1101/2022.01.27.22269902 doi: medRxiv preprint Continuous data has been presented as median (25th-75th centiles) while categorical data has been presented as percentages. Pearson's correlation was used to analyze the association between IgG titers and clinical scores. The independent-sample t-test was used to compare between two groups. Statistical analysis was performed using Statistical Package for the Social Sciences version 21.0 (SPSS, Inc.; Chicago, IL, USA) for Windows. p-Value <0.05 was considered statistically significant. A total of 74 students studying at BKL Walawalkar rural medical college, were included in the study. c) Table 4 indicates, additional infection with SARS-CoV2 bolsters IgG titers in vaccinated individuals. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 28, 2022. ; https://doi.org/10.1101/2022.01.27.22269902 doi: medRxiv preprint d) As the secondary objective was to know the SARS-CoV-2 anti-spike IgG titer and its association with immunity to SARS-CoV-2 re-infection. As . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 28, 2022. No mortality (Group 4, which is the cohort of Post-vaccination hospitalized patients who were suffering with moderate to severe covid disease, has IgG titers in the range of 2900 to 40000 AU/ml, with the mean of 7000 AU/ml. This is the group of 10 cases of severe disease, none died and they contracted infection within a short span of vaccination) . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 28, 2022. are reported from India. 78 Also, we observed that following a covid appropriate and covid preventive rules such as the use of face masks, maintaining social distancing, proper and regular hand washes, limiting social contact and gatherings, etc., had a huge impact on containing the transmission of infection among the exposed. It is beyond doubt that vaccines may have a greater impact on reducing viral circulation than naturally acquired immunity. The study by Tartof et al. observed that vaccines decrease disease severity among individuals who do acquire infection i.e., breakthrough infections. 9 The mechanisms by which COVID-19 vaccination elicits disease attenuation are largely unknown but are likely due to the recall of immunologic memory responses that reduce viral replication and accelerate the elimination of virally infected cells. Studies of viral dynamics further suggest that while viral loads in breakthrough infections may be as high in vaccinated individuals as they are in unvaccinated individuals, viral loads in those who are vaccinated decline more rapidly, and the virus that they shed is less likely to be culture-positive than virus shed by unvaccinated individuals. 1011 This suggests that people who are fully vaccinated are less likely to become infected and if infected, will be contagious for shorter periods than unvaccinated. 12 Vaccines not only decrease transmission rates but also decrease disease severity among individuals who do acquire infection. This is very well supported by the present study by two means, one the . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Nonetheless, the fact that vaccinated individuals can still become ill enough with COVID-19 to be hospitalized is understandably concerning. Even though vaccines are widely regarded as the most effective means of halting and terminating the Covid-19 outbreak, vaccine efficacy differs in the real world due to a variety of factors than reported. 13 Hence, other preventive measures such as Covid appropriate behavior which determines the degree of exposure to the virus also play a major role in preventing breakthrough infections. And our study strongly underscored the role of covid appropriate behavior and its additive effect on vaccine protection. 4 A valuable new study by Tenforde and colleagues affirms the vaccine efficacy against hospitalization also depends on patients' immune status, age, vaccine preparation, time since vaccination, and Covid appropriate behavior among other parameters studied. The study further suggests that vaccines along with appropriate preventive measures are associated with a lower likelihood of infection and also transmission. 14 Vaccination is the better effect when combined with better CAB, as all those who contracted covid breakthrough infections fared on the lower scale on CAB score in our study. This may have underlined the message that avoiding those contacts that are on the lower scale on CAB score (whose behavior is not in compliance with guidelines to prevent respiratory droplet infections) and avoiding close and crowded rooms is better for infection prevention. This warrants better awareness programs for propagating the importance of covid appropriate behavior. Of given the recent variants (omicron) and imminent variants of whatsoever nature, our study underlines the importance of vaccination and CAB. Antibody response to SARS-Co-V 2: Evidence through multiple studies shows that protective antibody titers even though correlate well at the population level, are still 1 4 elusive at the individual level 15 . A positive antibody test is currently recommended only to detect an individual with prior infection but cannot be used to assess the level of protection provided by the immune system in post-vaccinated individuals. However, a study by Bates et al. suggests that even though the breakthrough infections in patients were mild, there is a substantial increase of humoral immunity similar to the findings in our study. 16 18 The decline in IgG titers is expected; but how these titers relate to protection from subsequent re-infections (Symptomatic or severe covid disease and death) remain elusive. An individual with a low or undetectable level of SARS-COV -2 antibodies have an increased risk of shedding infectious viruses. 19 Effectiveness of vaccination and antibodybased -correlates of this protection are a potential strength of serological testing to identify those who are immune. Though this is a humongous and complex but a very novel aim, for which larger and complex studies are required. Studies with 'Long longitudinal cohorts with baseline immunology' are needed. This small study throws some insights for future studies. This present outbreak could be because a new unknown Covid variant that demands genomic sequencing and continuous surveillance. Unusual outbreaks like this and changing ecology of pandemic calls for deeper genomic and mechanistic studies. The B.1.617.2 (Delta) variant of (SARS-CoV-2) was first identified in the state of . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 28, 2022. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial Covaxin efficacy 78% in Phase 3 analysis | Latest News India -Hindustan Times Antibody response after first and second-dose of ChAdOx1-nCOV (Covishield TM®) and BBV-152 (Covaxin TM®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study COVID-19 Vaccine Breakthrough Case Investigation and Reporting | CDC Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine Breakthrough SARS-CoV-2 infections among BBV-152 (COVAXIN®) and AZD1222 (COVISHIELD TM ) recipients: Report from the eastern state of India Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution. medRxiv Prepr Serv Heal Sci Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study Effect of Vaccination on Transmission of SARS-CoV-2 Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity National Center for Immunization and Respiratory Diseases (NCIRD) D of VD. Science Brief: SARS-CoV-2 Infection-induced and Vaccine-induced Immunity Sci Briefs Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3 Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion